Catalyst Wire Dossier Catalyst Wire Dossier

QLT091001

retinoid · QLT Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for QLT091001, covering 2009-03-30 to 2015-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Effects of Oral QLT091001 in Adults With Impaired Dark Adaptation [Phase 2]

See pricing